High-Dose Spironolactone for Acne in Patients with Polycystic Ovarian Syndrome: A Single-Institution Retrospective Study

    August 2019 in “ Journal of The American Academy of Dermatology ”
    Pallavi Basu, Scott A. Elman, Boya Abudu … Rachel V. Reynolds
    Studysummary This report shares the authors' experience using spironolactone for treating acne in a PCOS clinic, but provides no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review American Journal of Clinical Dermatology · 2017
    2. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome JAMA Dermatology · 2015
    3. Polycystic Ovary Syndrome: A Review for Dermatologists Journal of The American Academy of Dermatology · 2014

    Related research 4

    1. How to Treat Acne in Women with Polycystic Ovary Syndrome (PCOS): Review of the Available Literature Journal of Education, Health and Sport · 2022
    2. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism Actas Dermo-Sifiliográficas · 2020
    3. High-Dose Spironolactone for Acne in Patients with Polycystic Ovarian Syndrome: A Single-Institution Retrospective Study Journal of The American Academy of Dermatology · 2019
    4. Antiandrogen Treatment of Polycystic Ovary Syndrome Endocrinology and Metabolism Clinics of North America · 1999